| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
454 |
403 |
$34K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
359 |
258 |
$13K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
359 |
258 |
$13K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
323 |
224 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
64 |
59 |
$5K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
175 |
144 |
$5K |
| 96127 |
|
177 |
145 |
$3K |
| 99459 |
|
173 |
168 |
$2K |
| 86780 |
|
176 |
144 |
$2K |
| 86803 |
|
153 |
120 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
25 |
18 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
33 |
26 |
$2K |
| 87340 |
|
152 |
120 |
$2K |
| 81025 |
|
147 |
138 |
$823.88 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
108 |
85 |
$619.92 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
19 |
16 |
$544.54 |
| 86762 |
|
35 |
26 |
$352.45 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
36 |
34 |
$244.80 |
| 96160 |
|
12 |
12 |
$175.20 |